Jianyin medical funds heavily into lanling cosmetics packaging production

To lanling cosmetics packaging production, jianyin medical fund is not only a vaccine in the market. Jianyin health-care fund marketing director, said: 'jianyin health-care fund will invest in the pharmaceutical, medical equipment, medical institutions, medical care, rehabilitation care. '
jianyin insiders said:' the fund total investment principle is the development period, have mature profit of the enterprise. 'Standards, investment lanling cosmetics packaging production plug silver health-care fund seems to be built doesn't fit. These people interpreted as: 'we pay more attention to the quality of the project itself, as long as it is within the industry first-class enterprise, we will focus on. '
lanling cosmetics packaging production after big star without smell, the company was founded in 1990, mainly engaged in pharmaceutical packaging business. 1 to August 2009, the company sales income 3. 600 million yuan, the scale is not big. However, lanling cosmetics packaging production plug is currently Asia's largest pharmaceutical packaging materials specializing in the production of enterprises, almost monopoly domestic vaccine and infusion packaging market.
', according to national statistics, the company's market share is 80%, the current lanling ready to enter the field of the world's top three. 'Lanling cosmetics packaging production plug the chairman guo-ping hua told reporters,' now all domestic a/h1n1 flu vaccines are lanling products 100%. Because the vaccine production in July, after outbreak of qiu dong season vaccine production and demand is expected to grow, the company this year's flu vaccine sales packaging will amount to 100 million. '
is affected by the pandemic, guo-ping hua said lanling cosmetics packaging production plug will make future high-speed growth, income growth is expected to more than 30%. But due to the low cost, the company product margins above 80%.
jianyin health-care fund investment is determined for each is not lower than a, guo-ping hua said: 'the jianyin investment scale is more than one. As strategic investors, they will bring to the company of professional financial management and all kinds of social and financial resources. '
there are seasonal flu outbreak, however, large outbreaks have some accidental, corporate earnings expectations with fluctuation will be big. To this, guo-ping hua said: 'at present, the company 20% of products exported to Europe, the Middle East and South Korea and other places, we also explore other areas of packaging. Jianyin lanling, mainly is because the growth of the company. '
it is understood that the investment will be mainly used for lanling plug cephalosporin products packaging of cosmetics and no die edge products of scientific research, these projects can be put into production within a year. China says, high-end drug packaging will be the future main direction of the company.